Why fragmented NHS private care pathways put patients at risk

As NHS waiting lists continue to grow and demand for timely treatment mounts, the partnership between NHS services and independent providers has become a routine part of healthcare delivery in the UK.

More patients now move between sectors for diagnostics, procedures and follow-up care than ever before. While this mixed model expands capacity, it also introduces a persistent challenge: safeguarding patient safety when care is delivered across multiple organisations with different systems, standards and governance structures.

Although patients may assume that their healthcare journey is coordinated behind the scenes, often essential information does not always move with the clinician resulting to fragmentation of clinical records becoming a significant risk.

When patients undergo imaging or surgery in a private hospital and later present to the NHS with complications, treating clinicians may not have immediate access to operative notes, investigation results or the details of previous assessments. According to patient-safety experts, incomplete or delayed documentation can affect the accuracy of clinical decision-making and influence how early deterioration is recognised or escalated. 

Concerns also arise around clinical responsibility. When complications occur following privately delivered procedures, patients frequently turn to NHS services for urgent or ongoing care. However, clinicians in the NHS may be uncertain about who is responsible for specific aspects of follow-up, how complications should be communicated back to the independent provider, or whether shared management plans are in place. Patient-safety practitioners note that this uncertainty can cause delays at critical points in the pathway and lead to confusion for both staff and patients.

Variation in governance standards across providers adds further complexity. While both NHS and private organisations are subject to regulation, their internal governance structures and incident-review processes can differ considerably.

High-volume services commissioned to reduce NHS backlogs may expand rapidly, sometimes before comprehensive audit and oversight mechanisms are fully embedded. Clinical governance specialists highlight that, without consistent review processes, emerging patterns of complications or near-misses may not be identified as quickly as they should be. For NHS commissioners and provider boards, this presents an ongoing challenge. Their role is not only to secure additional capacity but also to maintain assurance that contracted services meet expected safety and quality standards. In practice, commissioners often report uneven visibility of complication rates, escalation arrangements and governance results across different external providers. 

Against this backdrop, the value of independent clinical expertise has become increasingly recognised. At TMLEP, we are frequently engaged to review incidents that span multiple providers, offering impartial analysis of care across the full pathway. Independent investigators are able to reconstruct the sequence of events using documentation from both sectors, assess the clinical reasoning involved, and identify where communication or governance gaps may have contributed to the outcome. According to investigation specialists, incidents involving more than one organisation often reveal systemic issues rather than isolated errors.

Independent bodies also support proactive improvement work. This may include auditing how effectively information is shared between providers, reviewing documentation and consent processes, and assessing whether escalation pathways are aligned across NHS and independent settings. These activities help organisations identify governance weaknesses early and strengthen collaborative working.

As the NHS continues to rely on a blended model of in-house and outsourced capacity, consistent governance and communication across sectors are essential. Patients experience their care as a single, continuous pathway, even when multiple organisations are involved. Ensuring that this pathway is safe and coordinated requires clear responsibilities, aligned standards and shared learning.

Independent clinical review offers a practical mechanism to achieve this, by identifying where fragmented systems create risk and supporting organisations to implement improvements. TMLEP play a key role in ensuring that the increasing complexity of modern healthcare does not compromise patient safety. With coherent oversight and collaborative governance, the NHS and private sector can work together to deliver safer, more joined-up care for all patients.